Utility of NGS Assays for the Evaluation of Lymphoid Malignancies – Webinar
This webinar will explore how insights gained through NGS translate to the development of improved treatment of lymphoid malignancies.
25Feb
News
30Jan
Webinar: Capsid titre quantification for AAV-based therapeutics
Cell and gene therapies require development of fit for purpose analytical tools to support bioprocess development, for biopharmaceutical characterization and lot release testing.
10Apr
Webinar: Development of sensitive ADA assays using automated acid dissociation in Gyrolab Mixing CD 96
Measuring Anti-Drug-Antibody (ADA) levels is an important part of developing new biologics. The clinical implication of the presence of anti-drug-antibodies in treated patients may include allergic reactions, immune complex toxicity, autoimmune reactions and reduction of efficacy.
19Feb
Webinar: Multiplex assays of the anti-apoptotic BCL-2 family
Multiplex assays of the anti-apoptotic BCL-2 family
A hallmark of cancer cells is defects in the apoptotic cell death program.